Notice: This company has been marked as potentially delisted and may not be actively trading. TradeUP Acquisition (UPTD) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends UPTD vs. COEP, EVAX, BCLI, KLTO, ONVO, APTO, CELZ, BCDA, FRTX, and SLXNShould you be buying TradeUP Acquisition stock or one of its competitors? The main competitors of TradeUP Acquisition include Coeptis Therapeutics (COEP), Evaxion Biotech A/S (EVAX), Brainstorm Cell Therapeutics (BCLI), Klotho Neurosciences (KLTO), Organovo (ONVO), Aptose Biosciences (APTO), Creative Medical Technology (CELZ), BioCardia (BCDA), Fresh Tracks Therapeutics (FRTX), and Silexion Therapeutics (SLXN). These companies are all part of the "biological products, except diagnostic" industry. TradeUP Acquisition vs. Coeptis Therapeutics Evaxion Biotech A/S Brainstorm Cell Therapeutics Klotho Neurosciences Organovo Aptose Biosciences Creative Medical Technology BioCardia Fresh Tracks Therapeutics Silexion Therapeutics Coeptis Therapeutics (NASDAQ:COEP) and TradeUP Acquisition (NASDAQ:UPTD) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, community ranking, media sentiment, valuation and institutional ownership. Does the MarketBeat Community believe in COEP or UPTD? Coeptis Therapeutics received 5 more outperform votes than TradeUP Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformCoeptis TherapeuticsOutperform Votes583.33% Underperform Votes116.67%TradeUP AcquisitionN/AN/A Which has stronger earnings and valuation, COEP or UPTD? TradeUP Acquisition has lower revenue, but higher earnings than Coeptis Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCoeptis Therapeutics$80K99.66-$21.27M-$0.29-0.67TradeUP AcquisitionN/AN/A-$1MN/AN/A Is COEP or UPTD more profitable? TradeUP Acquisition's return on equity of 0.00% beat Coeptis Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Coeptis TherapeuticsN/A -1,094.50% -219.97% TradeUP Acquisition N/A N/A -3.38% Do institutionals & insiders have more ownership in COEP or UPTD? 13.9% of Coeptis Therapeutics shares are held by institutional investors. Comparatively, 35.0% of TradeUP Acquisition shares are held by institutional investors. 24.3% of Coeptis Therapeutics shares are held by company insiders. Comparatively, 55.1% of TradeUP Acquisition shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has more risk & volatility, COEP or UPTD? Coeptis Therapeutics has a beta of -0.94, suggesting that its stock price is 194% less volatile than the S&P 500. Comparatively, TradeUP Acquisition has a beta of 0.12, suggesting that its stock price is 88% less volatile than the S&P 500. Do analysts prefer COEP or UPTD? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Coeptis Therapeutics 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00TradeUP Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer COEP or UPTD? In the previous week, TradeUP Acquisition's average media sentiment score of 0.67 beat Coeptis Therapeutics' score of 0.00 indicating that TradeUP Acquisition is being referred to more favorably in the news media. Company Overall Sentiment Coeptis Therapeutics Neutral TradeUP Acquisition Positive SummaryTradeUP Acquisition beats Coeptis Therapeutics on 7 of the 10 factors compared between the two stocks. Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Get TradeUP Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for UPTD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPTD vs. The Competition Export to ExcelMetricTradeUP AcquisitionBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.00M$2.95B$5.08B$8.80BDividend YieldN/A1.91%5.02%4.07%P/E RatioN/A17.5291.2813.60Price / SalesN/A280.411,226.2187.40Price / CashN/A169.3839.4536.27Price / Book-0.584.366.906.33Net Income-$1M-$41.63M$118.83M$225.93M TradeUP Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPTDTradeUP AcquisitionN/A$0.92+8.2%N/A-37.4%$2.00MN/A0.002,021Gap DownCOEPCoeptis TherapeuticsN/A$0.19+0.1%N/A-83.3%$7.97M$80,000.000.002EVAXEvaxion Biotech A/S3.1821 of 5 stars$1.35-3.6%$11.00+714.8%-81.7%$7.93M$70,000.000.0049BCLIBrainstorm Cell Therapeutics4.4474 of 5 stars$1.23-2.4%$30.00+2,339.0%-53.4%$7.01MN/A0.0040Analyst UpgradePositive NewsKLTOKlotho NeurosciencesN/A$0.32-5.9%N/AN/A$5.51MN/A0.00N/AONVOOrganovo0.6793 of 5 stars$0.35+0.0%N/A-72.7%$5.38M$110,000.00-0.3320Analyst ForecastNews CoverageAPTOAptose Biosciences1.9913 of 5 stars$0.28+2.5%$4.33+1,447.6%-90.0%$5.07MN/A-0.0931Analyst ForecastNews CoverageGap DownCELZCreative Medical Technology1.7223 of 5 stars$2.49-2.4%N/A-41.6%$4.36M$10,000.00-0.675Analyst RevisionPositive NewsGap DownBCDABioCardia3.0529 of 5 stars$2.03+2.0%$25.00+1,131.5%-81.6%$4.30M$480,000.00-0.4916Analyst RevisionGap UpFRTXFresh Tracks TherapeuticsN/A$0.72flatN/A-9.5%$4.27M$8.01M0.0020SLXNSilexion TherapeuticsN/A$0.27-19.0%$1.00+270.5%N/A$3.73MN/A0.00N/ANews CoverageGap Down Related Companies and Tools Related Companies Brainstorm Cell Therapeutics Alternatives Klotho Neurosciences Alternatives Organovo Alternatives Aptose Biosciences Alternatives Creative Medical Technology Alternatives BioCardia Alternatives Fresh Tracks Therapeutics Alternatives Silexion Therapeutics Alternatives Genetic Technologies Alternatives Gritstone bio Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:UPTD) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TradeUP Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share TradeUP Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free UPTD Stock Alerts